T 2618/19 (Everolimus solid brain tumour/NOVARTIS) of 18.09.2020
- European Case Law Identifier
- ECLI:EP:BA:2020:T261819.20200918
- Date of decision
- 18 September 2020
- Case number
- T 2618/19
- Petition for review of
- -
- Application number
- 14164565.5
- IPC class
- A61P 35/00A61K 31/436
- Language of proceedings
- English
- Distribution
- No distribution (D)
- Download
- Decision in English
- OJ versions
- No OJ links found
- Other decisions for this case
- -
- Abstracts for this decision
- -
- Application title
- Treatment of solid brain tumours with a rapamycin derivative
- Applicant name
- Novartis AG
- Opponent name
- Generics (U.K.) Limited
Ethypharm - Board
- 3.3.01
- Headnote
- -
- Relevant legal provisions
- European Patent Convention Art 113(2) (2007)
- Keywords
- Basis of decision - agreement to text withdrawn by patent proprietor
- Catchword
- -
- Cited cases
- T 0073/84
- Citing cases
- -
Order
For these reasons it is decided that:
1. The decision under appeal is set aside.
2. The patent is revoked.